SCHEMBL14083699

SCHEMBL14083699

O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccc(-c2ncccc2Cl)c(F)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ MEN1 O00255 5/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ LMNA P02545 2/20 0.53
▸ RXFP1 Q9HBX9 2/20 0.53
▸ CASP3 P42574 1/20 0.50
▸ TAAR1 Q96RJ0 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ MAPT P10636 3/20 0.49
▸ SIRT2 Q8IXJ6 3/20 0.49
▸ SIRT3 Q9NTG7 3/20 0.49
▸ CYP11B1 P15538 1/20 0.49
▸ CYP11B2 P19099 1/20 0.49
▸ NR1H4 Q96RI1 1/20 0.48
▸ SIRT1 Q96EB6 2/20 0.47
▸ SCD O00767 1/20 0.47
▸ TRPV1 Q8NER1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083820 0.88 MEN1 (0.58) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL14083719 0.87 NPC1 (0.56) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL14083633 0.87 TRPV1 (0.54) RAB9ANPC1CYP11B1CYP11B2TRPV1
SCHEMBL14083711 0.86 MAPT (0.54) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL14083634 0.85 RAB9A (0.53) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL14083862 0.84 RAB9A (0.65) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL14083635 0.84 TRPV1 (0.56) MEN1KMT2ATRPV1
SCHEMBL14083707 0.84 TRPV1 (0.56) MEN1KMT2ACYP11B1CYP11B2TRPV1
SCHEMBL14083713 0.83 ABL1 (0.61) SMN1; SMN2MEN1KMT2ATRPV1
SCHEMBL14083695 0.82 NPC1 (0.53) RAB9ANPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 RAB9A 1914/4885NPC1 1061/4885SMN1; SMN2 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback